Clinical Trial Update: An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Open-label Phase 1 trial evaluating Cizutamig in patients with seropositive rheumatoid arthritis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Cizutamig

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Rheumatoid Arthritis (RA) | Phase 1 | Status: RECRUITING